Bowlva Lee, DO
Pain Medicine · Dallas, TXNPI 1053631259
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,496 of the $8,369 with a category attached, or 77.6%. It is spread thinly across 14 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,531 and has fallen 95.2% since, to $168 in 2025.
Across 175 payments — averaging $47.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$2K
- Nevro Corp.$2K
- Boston Scientific$2K
- Scilex Pharmaceuticals Inc.$291
- Si-bone, Inc.$261
- plus $766 from 8 others
What the payments were for
- Travel & lodging$1,87322%
- Food & beverage$6,49678%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 41 | $1,858 |
| Abbott | 36 | $1,829 |
| Nevro Corp. | 42 | $1,811 |
| Boston Scientific | 24 | $1,553 |
| Scilex Pharmaceuticals Inc. | 13 | $291 |
| Si-bone, Inc. | 3 | $261 |
| Vertiflex, Inc. | 3 | $259 |
| Angiodynamics, Inc. | 1 | $177 |
| AbbVie | 4 | $132 |
| SPR Therapeutics, Inc | 3 | $95 |
| Nalu Medical, Inc. | 2 | $31 |
| Medical Device Business Services, Inc. | 1 | $30 |
| IBSA Pharma Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,369 in reported general payments places this provider in the 70th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 151 | $3,027 |
| Gabapentin | 128 | $1,699 |
| Lidocaine | 24 | $1,538 |
| Tizanidine Hcl | 64 | $746 |
| Diclofenac Sodium | 29 | $662 |
| Celecoxib | 37 | $550 |
| Cyclobenzaprine Hcl | 98 | $528 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $402 |
| Pregabalin | 19 | $291 |
| Tramadol Hcl | 35 | $217 |
| Methocarbamol | 13 | $114 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Dallas
- Justin ThompsonDallas$45K
- Demaceo HowardDallas$39K
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.